Covered recipient · General Payments record
NATALIE JILL BOWLES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021–2024
$1,928.75
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.48 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exeltis, USA Inc. | $123.11 | 6 |
| Novo Nordisk AS | $53.44 | 3 |
| PFIZER INC. | $38.07 | 2 |
| Daiichi Sankyo Inc. | $24.24 | 1 |
| ABBVIE INC. | $23.01 | 1 |
| Astellas Pharma US Inc | $18.48 | 1 |
| CooperSurgical, Inc. | $16.52 | 1 |
| SHIELD THERAPEUTICS INC | $14.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.01 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807526 | CMS |
| Astellas Pharma US Inc | $18.48 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139473842 | CMS |
| CooperSurgical, Inc. | $16.52 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150802214 | CMS |
| Daiichi Sankyo Inc. | $24.24 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089402195 | CMS |
| Exeltis, USA Inc. | $20.56 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150009384 | CMS |
| Exeltis, USA Inc. | $24.23 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150009386 | CMS |
| Exeltis, USA Inc. | $23.69 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150009388 | CMS |
| Exeltis, USA Inc. | $18.37 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150009390 | CMS |
| Exeltis, USA Inc. | $14.69 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150009392 | CMS |
| Exeltis, USA Inc. | $21.57 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150009394 | CMS |
| Novo Nordisk Inc | $18.51 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100252948 | CMS |
| Novo Nordisk Inc | $13.09 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100259221 | CMS |
| Novo Nordisk Inc | $21.84 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100284074 | CMS |
| PFIZER INC. | $20.05 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131628622 | CMS |
| PFIZER INC. | $18.02 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131511428 | CMS |
| SHIELD THERAPEUTICS INC | $14.61 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150126711 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.